To evaluate in vivo safety and efficacy of hair care formulation in terms of improvement in hair thickness and reduction in hair fall on healthy human subjects - NI

Patanjali Ayurved Limited0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年8月19日

试验速览

暂无简介。

•1. Indian female subjects
•2. Healthy subjects
•3. Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….)
•4. Having mild to moderate hair fall
•5. Having dull and dry hair with split ends

•1. For female: Being pregnant or breastfeeding or having stopped to breastfeed in the past three
•2. Having refused to give his/her assent by not signing the consent form
•3. Taking part in another study liable to interfere with this study4. Being insulin-dependent diabetic or non-insulin-dependent diabetic with a recent therapy (less than 6 months)
•5. Having a progressive asthma (either under treatment or last fit in the last 2 years)
•6. Being epileptic.
•7. Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months)
•8. Having cutaneous hypersensitivity
•9. Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products.
•10. Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol)
•11. Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.

发起方

Patanjali Ayurved Limited